Analysis of the pH Dependence of the Neonatal Fc Receptor/Immunoglobulin G Interaction Using Antibody and Receptor Variants
The DOI matches its Crossref record.
Abstract
The neonatal Fc receptor (FcRn) binds maternal immunoglobulin G (IgG) from ingested milk in the gut (pH 6.0-6.5) and delivers it to the bloodstream of the newborn (pH 7.0-7.5). A soluble version of FcRn reproduces the physiological pH-dependent interaction with IgG, showing high-affinity binding at pH 6.0-6.5 but weak or no binding at pH 7.0-7.5. We have studied the pH dependence of the FcRn/IgG interaction using a surface plasmon resonance assay to measure kinetic and equilibrium constants. We show that the affinity of FcRn for IgG is reduced about 2 orders of magnitude as the pH is raised from 6.0 to 7.0. A hill put analysis suggests that several titrating residues participate in the pH-dependent affinity transition. Histidine side chains are likely candidate for residues that titrate between pH 6.0 and 7.0, and previous biochemical and structural work identified several histidines on the Fc portion of IgG that are located at the FcRn binding site. Using mutant IgG molecules and IgG subtype variants that differ in the number of histidines at the IgG/FcRn interface, we demonstrate that IgG histidines located at the junction between the CH2 and CH3 domains (residues 310 and 433) contribute to the pH-dependent affinity transition. Experiments with a mutant FcRn molecule show that two histidines on the FcRn heavy chain (residues 250 and 251) also contribute to the pH dependence of the FcRn/IgG interaction. There results are interpreted using the crystal structures of FcRn and an FcRn/Fc complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This characteristic is likely mediated, at least in part, via protonation of histidine residues (the only amino acid that changes between pH 5.5 and 7.4) at the CH2–CH3 domain interface of IgG (54–56).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [54]
In the citing paper
“the interaction of FcRn with IgG displays a strong pH dependence, such that high-affinity binding occurs at pH 6.0, but little or no binding occurs at physiological pH 7.4 (54).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [54]
Citations
Cites
Still being checked.
Cited by
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Daëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
The effects of extracellular pH on immune function
Lardner, A. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.522 · Cited by 864
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
Keizer, R. J., Huitema, A. D. R., Schellens, J. H. M., & Beijnen, J. H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531280-000000000-00000 · Cited by 725
Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)
Dall'Acqua, W. F., Kiener, P. A., & Wu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604292200 · Cited by 646
Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors
Myszka, D. G. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80157-7 · Cited by 552
Ober, R. J., Radu, C. G., Ghetie, V., & Ward, E. S. (2001) · International Immunology · doi:10.1093/intimm/13.12.1551 · Cited by 501
Elimination mechanisms of therapeutic monoclonal antibodies
Tabrizi, M. A., Tseng, C.-M. L., & Roskos, L. K. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03638-x · Cited by 478
The effects of pH on wound healing, biofilms, and antimicrobial efficacy
Percival, S. L., McCarty, S., Hunt, J. A., & Woods, E. J. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12125 · Cited by 471
Multiple Roles for the Major Histocompatibility Complex Class I– Related Receptor FcRn
Ghetie, V., & Ward, E. S. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.739 · Cited by 474
Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line
Dickinson, B. L., Badizadegan, K., Wu, Z., Ahouse, J. C., Zhu, X., Simister, N. E., Blumberg, R. S., & Lencer, W. I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6968 · Cited by 434
The Neonatal Fc Receptor (FcRn): A Misnomer?
Pyzik, M., Sand, K. M. K., Hubbard, J. J., Andersen, J. T., Sandlie, I., & Blumberg, R. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01540 · Cited by 429
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
Vaccaro, C., Zhou, J., Ober, R. J., & Ward, E. S. (2005) · Nature Biotechnology · doi:10.1038/nbt1143 · Cited by 407
“The current model for FcRn function is as follows: IgGs are taken up into cells, most likely by fluid-phase pinocytosis, as the near-neutral pH of the extracellular milieu is generally not permissive for FcRn-IgG interaction”
BackgroundCrystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Martin, W. L., West, A. P., Gan, L., & Bjorkman, P. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00230-1 · Cited by 391
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function
James, L. C., Keeble, A. H., Khan, Z., Rhodes, D. A., & Trowsdale, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609174104 · Cited by 386
Suzuki, T., Ishii-Watabe, A., Tada, M., Kobayashi, T., Kanayasu-Toyoda, T., Kawanishi, T., & Yamaguchi, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903296 · Cited by 368
Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences
Acqua, W. F. D., Woods, R. M., Ward, E. S., Palaszynski, S. R., Patel, N. K., Brewah, Y. A., Wu, H., Kiener, P. A., & Langermann, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5171 · Cited by 368
Allez, M., Karmiris, K., Louis, E., Van Assche, G., Ben-Horin, S., Klein, A., Van der Woude, J., Baert, F., Eliakim, R., Katsanos, K., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2010.04.004 · Cited by 334
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Saunders, K. O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01296 · Cited by 316
Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn
Ober, R. J., Martinez, C., Vaccaro, C., Zhou, J., & Ward, E. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2021 · Cited by 314
Fc RECEPTORS AND THEIR INTERACTIONS WITH IMMUNOGLOBULINS
Raghavan, M., & Bjorkman, P. J. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.181 · Cited by 314
Self-citationFiran, M., Bawdon, R., Radu, C., Ober, R. J., Eaken, D., Antohe, F., Ghetie, V., & Ward, E. S. (2001) · International Immunology · doi:10.1093/intimm/13.8.993 · Cited by 330
The therapeutic age of the neonatal Fc receptor
Pyzik, M., Kozicky, L. K., Gandhi, A. K., & Blumberg, R. S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00821-1 · Cited by 288
Stapleton, N. M., Andersen, J. T., Stemerding, A. M., Bjarnarson, S. P., Verheul, R. C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., et al. (2011) · Nature Communications · doi:10.1038/ncomms1608 · Cited by 286
Gitlin, I., Carbeck, J. D., & Whitesides, G. M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502530 · Cited by 286
An Engineered Human IgG1 Antibody with Longer Serum Half-Life
Hinton, P. R., Xiong, J. M., Johlfs, M. G., Tang, M. T., Keller, S., & Tsurushita, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.346 · Cited by 282
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Rath, T., Baker, K., Dumont, J. A., Peters, R. T., Jiang, H., Qiao, S.-W., Lencer, W. I., Pierce, G. F., & Blumberg, R. S. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2013.834293 · Cited by 281
Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates
Hinton, P. R., Johlfs, M. G., Xiong, J. M., Hanestad, K., Ong, K. C., Bullock, C., Keller, S., Tang, M. T., Tso, J. Y., Vásquez, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300470200 · Cited by 273
Structure and Stability Changes of Human IgG1 Fc as a Consequence of Methionine Oxidation
Liu, D., Ren, D., Huang, H., Dankberg, J., Rosenfeld, R., Cocco, M. J., Li, L., Brems, D. N., & Remmele, R. L. (2008) · Biochemistry · doi:10.1021/bi702238b · Cited by 261
Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms
Oganesyan, V., Damschroder, M. M., Cook, K. E., Li, Q., Gao, C., Wu, H., & Dall'Acqua, W. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537563 · Cited by 259
“Finally, it has generally been assumed using rodent molecules that IgG/FcRn pH-dependent interaction relies on the titration of Fc His(310)/His(433) and FcRn His(250)/His(251) (5, 34).”
BackgroundNeonatal Fc Receptor: From Immunity to Therapeutics
Kuo, T. T., Baker, K., Yoshida, M., Qiao, S.-W., Aveson, V. G., Lencer, W. I., & Blumberg, R. S. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9468-4 · Cited by 247
Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
Kontermann, R. E. (2009) · BioDrugs · doi:10.2165/00063030-200923020-00003 · Cited by 243
Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
Liu, R., Oldham, R., Teal, E., Beers, S., & Cragg, M. (2020) · Antibodies · doi:10.3390/antib9040064 · Cited by 238
Increasing the serum persistence of an IgG fragment by random mutagenesis
Ghetie, V., Popov, S., Borvak, J., Radu, C., Matesoi, D., Medesan, C., Ober, R. J., & Ward, E. S. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-637 · Cited by 241
Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level
Ober, R. J., Martinez, C., Lai, X., Zhou, J., & Ward, E. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402970101 · Cited by 258
Yeung, Y. A., Leabman, M. K., Marvin, J. S., Qiu, J., Adams, C. W., Lien, S., Starovasnik, M. A., & Lowman, H. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804182 · Cited by 237
Impact of methionine oxidation on the binding of human IgG1 to FcRn and Fcγ receptors
Bertolotti-Ciarlet, A., Wang, W., Lownes, R., Pristatsky, P., Fang, Y., McKelvey, T., Li, Y., Li, Y., Drummond, J., Prueksaritanont, T., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.002 · Cited by 235
Dostalek, M., Gardner, I., Gurbaxani, B. M., Rose, R. H., & Chetty, M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0027-4 · Cited by 230
Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn
Kim, J.-K., Firan, M., Radu, C. G., Kim, C.-H., Ghetie, V., & Ward, E. S. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2819::aid-immu2819>3.0.co;2-6 · Cited by 222
Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans
Ward, E. S. (2003) · International Immunology · doi:10.1093/intimm/dxg018 · Cited by 216
“... and 0.25 mg/ml IgG (Alexa 647-labeled wild-type hIgG1 or H435A), the cells were washed and chased in medium containing unlabeled IgG for varying times (0‐40 min; Fig. 3). All pulse‐chase experiments were carried out at 37∞C in medium (depleted of serum IgG) at pH 7. Pulsing at this pH precluded the possibility tha…”
BackgroundMethodInfluentialFcRn: the MHC class I-related receptor that is more than an IgG transporter
Ghetie, V., & Ward, E. S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01172-9 · Cited by 216
Montoyo, H. P., Vaccaro, C., Hafner, M., Ober, R. J., Mueller, W., & Ward, E. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810796106 · Cited by 211
“Most naturally occurring IgGs bind to FcRn at acidic pH, but not at near-neutral pH (6, 7); consequently, uptake into cells before endosomal sorting is primarily dependent on fluid phase processes (8, 9).”
BackgroundWilcox, C. R., Holder, B., & Jones, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01294 · Cited by 200
Junghans, R. P. (1997) · Immunologic Research · doi:10.1007/bf02786322 · Cited by 205
TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved
Keeble, A. H., Khan, Z., Forster, A., & James, L. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800159105 · Cited by 202
Pros and cons of different therapeutic antibody formats for recombinant antivenom development
Laustsen, A. H., María Gutiérrez, J., Knudsen, C., Johansen, K. H., Bermúdez-Méndez, E., Cerni, F. A., Jürgensen, J. A., Ledsgaard, L., Martos-Esteban, A., Øhlenschlæger, M., et al. (2018) · Toxicon · doi:10.1016/j.toxicon.2018.03.004 · Cited by 177
Datta-Mannan, A., Witcher, D. R., Tang, Y., Watkins, J., & Wroblewski, V. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607161200 · Cited by 170
Structural basis of pH-dependent antibody binding by the neonatal Fc receptor
Vaughn, D. E., & Bjorkman, P. J. (1998) · Structure · doi:10.1016/s0969-2126(98)00008-2 · Cited by 170
Chaparro-Riggers, J., Liang, H., DeVay, R. M., Bai, L., Sutton, J. E., Chen, W., Geng, T., Lindquist, K., Casas, M. G., Boustany, L. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.319764 · Cited by 166
The Immunologic Functions of the Neonatal Fc Receptor for IgG
Rath, T., Kuo, T. T., Baker, K., Qiao, S.-W., Kobayashi, K., Yoshida, M., Roopenian, D., Fiebiger, E., Lencer, W. I., & Blumberg, R. S. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9768-y · Cited by 156
Prabhat, P., Gan, Z., Chao, J., Ram, S., Vaccaro, C., Gibbons, S., Ober, R. J., & Ward, E. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700337104 · Cited by 157
Chapter 4 Multitasking by Exploitation of Intracellular Transport Functions
Ward, E. S., & Ober, R. J. (2009) · Advances in Immunology · doi:10.1016/s0065-2776(09)03004-1 · Cited by 156
Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention
Patel, D. D., & Bussel, J. B. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.015 · Cited by 169
Engineered therapeutic antibodies with improved effector functions
Kubota, T., Niwa, R., Satoh, M., Akinaga, S., Shitara, K., & Hanai, N. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01222.x · Cited by 168
Transcytosis and Catabolism of Antibody
Ghetie, V. F., & Ward, E. S. (2002) · Immunologic Research · doi:10.1385/ir:25:2:097 · Cited by 163
McCarthy, K. M., Yoong, Y., & Simister, N. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.7.1277 · Cited by 145
Datta‐Mannan, A., Witcher, D. R., Tang, Y., Watkins, J. D., Jiang, W., & Wroblewski, V. J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011734 · Cited by 140
How functional foods play critical roles in human health
Pang, G., Xie, J., Chen, Q., & Zhi-he, H. (2012) · Food Science and Human Wellness · doi:10.1016/j.fshw.2012.10.001 · Cited by 150
Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn
Baker, K., Qiao, S., Kuo, T. T., Kobayashi, K., Yoshida, M., Lencer, W. I., & Blumberg, R. S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0160-9 · Cited by 145
Andersen, J. T., & Sandlie, I. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.318 · Cited by 123
Amelioration of Experimental Autoimmune Myasthenia Gravis in Rats by Neonatal FcR Blockade
Liu, L., Garcia, A. M., Santoro, H., Zhang, Y., McDonnell, K., Dumont, J., & Bitonti, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5390 · Cited by 122
The Role of FcRn in Antigen Presentation
Baker, K., Rath, T., Pyzik, M., & Blumberg, R. S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00408 · Cited by 121
Dephosphorylation of ZAP-70 and inhibition of T cell activation by activated SHP1
Brockdorff, J., Williams, S., Couture, C., & Mustelin, T. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199908)29:08<2539::aid-immu2539>3.0.co;2-m · Cited by 89
Vaccaro, C., Bawdon, R., Wanjie, S., Ober, R. J., & Ward, E. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606304103 · Cited by 114
Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions
Abdeldaim, D. T., & Schindowski, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102402 · Cited by 129
Wright, A., Sato, Y., Okada, T., Chang, K. H., Endo, T., & Morrison, S. L. (2000) · Glycobiology · doi:10.1093/glycob/10.12.1347 · Cited by 111
Self-citationSachs, U. J. H., Socher, I., Braeunlich, C. G., Kroll, H., Bein, G., & Santoso, S. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02408.x · Cited by 110
Targeting FcRn to Generate Antibody-Based Therapeutics
Ward, E. S., & Ober, R. J. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.007 · Cited by 108
Extending human IgG half-life using structure-guided design
Booth, B. J., Ramakrishnan, B., Narayan, K., Wollacott, A. M., Babcock, G. J., Shriver, Z., & Viswanathan, K. (2018) · mAbs · doi:10.1080/19420862.2018.1490119 · Cited by 107
pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling
Borrok, M. J., Wu, Y., Beyaz, N., Yu, X.-Q., Oganesyan, V., Dall'Acqua, W. F., & Tsui, P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603712 · Cited by 105
Chen, Y., & Balthasar, J. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9395-9 · Cited by 109
Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells
Goebl, N. A., Babbey, C. M., Datta-Mannan, A., Witcher, D. R., Wroblewski, V. J., & Dunn, K. W. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0101 · Cited by 104
Chen, P., Li, C., Lang, S., Zhu, G., Reheman, A., Spring, C. M., Freedman, J., & Ni, H. (2010) · Blood · doi:10.1182/blood-2010-05-284919 · Cited by 101
Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury
Pyzik, M., Rath, T., Kuo, T. T., Win, S., Baker, K., Hubbard, J. J., Grenha, R., Gandhi, A., Krämer, T. D., Mezo, A. R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618291114 · Cited by 102
A comprehensive review of the neonatal Fc receptor and its application in drug delivery
Martins, J. P., Kennedy, P. J., Santos, H. A., Barrias, C. C., & Sarmento, B. F. C. C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.007 · Cited by 110
Gurbaxani, B. M., Cruz, L. L. D., Chintalacharuvu, K. R., & Morrison, S. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.032 · Cited by 105
Self-citationEngineered Synthetic Polymer Nanoparticles as IgG Affinity Ligands
Lee, S.-H., Hoshino, Y., Randall, A. Z., Zeng, Z., Baldi, P., Doong, R., & Shea, K. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303612d · Cited by 100
The neonatal Fc receptor plays a crucial role in the metabolism of IgG in livestock animals
Cervenak, J., & Kacskovıcs, I. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.10.300 · Cited by 121
Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery
Devriendt, B., Geest, B. G. D., Goddeeris, B. M., & Cox, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.006 · Cited by 106
Non‐classical MHC class I molecules on intestinal epithelial cells: mediators of mucosal crosstalk
Shao, L., Kamalu, O., & Mayer, L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00295.x · Cited by 98
Neonatal Fc Receptor Blockade by Fc Engineering Ameliorates Arthritis in a Murine Model
Patel, D. A., Puig-Canto, A., Challa, D. K., Montoyo, H. P., Ober, R. J., & Ward, E. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003780 · Cited by 93
Telleman, P., & Junghans, R. P. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00034.x · Cited by 91
Structural characterization of a human Fc fragment engineered for extended serum half-life
Oganesyan, V., Damschroder, M. M., Woods, R. M., Cook, K. E., Wu, H., & Dall’Acqua, W. F. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.01.026 · Cited by 89
Co‐localization of the neonatal Fcγ receptor and IgG in human placental term syncytiotrophoblasts
Kristoffersen, E. K., & Matre, R. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260741 · Cited by 90
Yip, V., Palma, E., Tesar, D. B., Mundo, E. E., Bumbaca, D., Torres, E. K., Reyes, N. A., Shen, B., Fielder, P. J., Prabhu, S., et al. (2014) · mAbs · doi:10.4161/mabs.28254 · Cited by 90
Identification of critical IgG binding epitopes on the neonatal Fc receptor
Vaughn, D. E., Milburn, C. M., Penny, D. M., Martin, W. L., Johnson, J. L., & Björkman, P. J. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1388 · Cited by 90
Sequences in antibody molecules important for receptor-mediated transport into the chicken egg yolk
Morrison, S. L., Mohammed, M. S., Wims, L. A., Trinh, R. K., & Etches, R. J. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00095-5 · Cited by 110
Self-citationSato, K., Nagai, J., Mitsui, N., Yumoto, R., & Takano, M. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.10.012 · Cited by 88
Targeting FcRn for the modulation of antibody dynamics
Ward, E. S., Devanaboyina, S. C., & Ober, R. J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.02.007 · Cited by 87
Lozano, N. A., Lozano, A., Marini, V., Saranz, R. J., Blumberg, R. S., Baker, K., Agresta, M. F., & Ponzio, M. F. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.12972 · Cited by 85
Spassov, V. Z., & Yan, L. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24230 · Cited by 87
FcRn: From Molecular Interactions to Regulation of IgG Pharmacokinetics and Functions
Challa, D. K., Velmurugan, R., Ober, R. J., & Ward, E. S. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_12 · Cited by 103
Stirling, C. M. A., Charleston, B., Takamatsu, H., Claypool, S. M., Lencer, W. I., Blumberg, R. S., & Wileman, T. E. (2005) · Immunology · doi:10.1111/j.1365-2567.2004.02121.x · Cited by 98
IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity
Yoshida, M., Masuda, A., Kuo, T. T., Kobayashi, K., Claypool, S. M., Takagawa, T., Kutsumi, H., Azuma, T., Lencer, W. I., & Blumberg, R. S. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0054-z · Cited by 91
Bai, Y., Ye, L., Tesar, D. B., Song, H., Zhao, D., Björkman, P. J., Roopenian, D. C., & Zhu, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115348108 · Cited by 77
Ternant, D., Arnoult, C., Pugnière, M., Dhommée, C., Drocourt, D., Pérouzel, É., Passot, C., Baroukh, N., Mulleman, D., Tiraby, G., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501780 · Cited by 82
Majumdar, R., Esfandiary, R., Bishop, S. M., Samra, H. S., Middaugh, C. R., Volkin, D. B., & Weis, D. D. (2014) · mAbs · doi:10.4161/19420862.2014.985494 · Cited by 76
Katz, B. A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1444 · Cited by 76
Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas
Olafsen, T., Betting, D. J., Kenanova, V. E., Salazar, F. B., Clarke, P. J., Said, J. W., Raubitschek, A. A., Timmerman, J. M., & Wu, A. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060426 · Cited by 84
Metadata
- Authors
- Raghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J.
- Affiliations
- California Institute of Technology (US)
- Northwell Health (US)
- University of California, Los Angeles (US)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-11-01
- Volume
- 34
- Issue
- 45
- Pages
- 14649-14657
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2065219066
- Cited by
- 317
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 12 · 2021: 15 · 2020: 13 · 2019: 8 · 2018: 18 · 2017: 13 · 2016: 8 · 2015: 17 · 2014: 20 · 2013: 13 · 2012: 15
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca016858-25)
- National Cancer Institute (CA-16858)
- National Institute of Allergy and Infectious Diseases (AI29470)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal health and immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- neonatal Fc receptor, IgG, pH-dependent binding, ligand-receptor interactions, binding affinity, maternal IgG transfer
- MeSH terms
- Antibodies, Monoclonal, Binding Sites, Computer Graphics, Histidine, Humans, Hydrogen-Ion Concentration, Immunoglobulin G, Infant, Newborn, Kinetics, Models, Molecular, Protein Binding, Receptors, Fc, Biosensing Techniques, Mutagenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.